On Friday, 2seventy bio Inc (NASDAQ: TSVT) was 6.97% up from the session before settling in for the closing price of $2.44. A 52-week range for TSVT has been $2.35 – $6.40.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 91.91% over the last five years. When this article was written, the company’s average yearly earnings per share was at 81.88%. With a float of $48.39 million, this company’s outstanding shares have now reached $51.51 million.
The firm has a total of 274 workers. Let’s measure their productivity. In terms of profitability, gross margin is 51.77%, operating margin of -313.09%, and the pretax margin is -207.25%.
2seventy bio Inc (TSVT) Breakdown of a Key Holders of the stock
Also, it is sometimes useful to examine the sentiment of large-scale investors toward 2seventy bio Inc stocks. The insider ownership of 2seventy bio Inc is 6.19%, while institutional ownership is 87.84%. The most recent insider transaction that took place on Jan 06 ’25, was worth 14,289. In this transaction an insider of this company sold 5,114 shares at a rate of $2.79, taking the stock ownership to the 147,365 shares. Before that another transaction happened on Jan 03 ’25, when Company’s insider sold 1,000 for $2.94, making the entire transaction worth $2,936. This insider now owns 152,479 shares in total.
2seventy bio Inc (TSVT) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 81.88% per share during the next fiscal year.
2seventy bio Inc (NASDAQ: TSVT) Trading Performance Indicators
You can see what 2seventy bio Inc (TSVT) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 4.95. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.95.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.86, a number that is poised to hit -0.17 in the next quarter and is forecasted to reach -0.47 in one year’s time.
Technical Analysis of 2seventy bio Inc (TSVT)
Analysing the last 5-days average volume posted by the [2seventy bio Inc, TSVT], we can find that recorded value of 0.27 million was lower than the volume posted last year of 0.35 million. As of the previous 9 days, the stock’s Stochastic %D was 22.51%. Additionally, its Average True Range was 0.21.
During the past 100 days, 2seventy bio Inc’s (TSVT) raw stochastic average was set at 8.97%, which indicates a significant decrease from 30.29% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 73.02% in the past 14 days, which was higher than the 71.84% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $3.41, while its 200-day Moving Average is $4.27. Now, the first resistance to watch is $2.69. This is followed by the second major resistance level at $2.77. The third major resistance level sits at $2.91. If the price goes on to break the first support level at $2.47, it is likely to go to the next support level at $2.33. Now, if the price goes above the second support level, the third support stands at $2.25.
2seventy bio Inc (NASDAQ: TSVT) Key Stats
There are 51,588K outstanding shares of the company, which has a market capitalization of 134.65 million. As of now, sales total 100,390 K while income totals -217,570 K. Its latest quarter income was 13,530 K while its last quarter net income were -9,930 K.
